These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1836505)

  • 1. Corticosterone response to 8-OH-DPAT after chronic administration of antidepressants.
    Akiyoshi J; Nagayama H; Tsuchiyama K; Yamada K; Miyamoto T; Ito Y; Yamauchi C; Oba A; Okada K; Kojima K
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):141-2. PubMed ID: 1836505
    [No Abstract]   [Full Text] [Related]  

  • 2. The lack of effect of repeated treatment with antidepressant drugs on the 8-OH-DPAT-induced increase in the serum corticosterone concentration.
    Przegaliński E; Warchoł-Kania A; Budziszewska B
    Pol J Pharmacol Pharm; 1989; 41(1):63-8. PubMed ID: 2531382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.
    O'Donnell JM; Grealy M
    Br J Pharmacol; 1992 Apr; 105(4):863-8. PubMed ID: 1387021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A; Mjellem-Jolly N; Hole K
    Neuropharmacology; 1992 Jan; 31(1):25-32. PubMed ID: 1531864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjection of 8-OH-DPAT into nucleus accumbens attenuates naloxone-induced morphine withdrawal syndrome.
    Dzoljic MR; v Ent M; Kaplan CD; Saxena PR
    Prog Clin Biol Res; 1990; 328():441-4. PubMed ID: 2137629
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 8-OH-DPAT on corticosterone after acute and chronic administration of antidepressants.
    Akiyoshi J; Tsuchiyama K; Yamada K; Oba A; Yamada K; Kojima K; Sasaki I; Nagayama H
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):93-103. PubMed ID: 7708935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain.
    Pandey SC; Isaac L; Davis JM; Pandey GN
    Eur J Pharmacol; 1991 Sep; 202(2):221-5. PubMed ID: 1839385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists.
    Gudelsky GA; Koenig JI; Meltzer HY
    Neuropharmacology; 1987 Jul; 26(7A):707-12. PubMed ID: 2957607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats.
    Korte SM; Van Duin S; Bouws GA; Koolhaas JM; Bohus B
    Eur J Pharmacol; 1991 May; 197(2-3):225-8. PubMed ID: 1833209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Aug; 185(1):11-8. PubMed ID: 2171956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN; Fozard JR
    Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the adrenal medulla in the metabolic and pressor actions of 8-OH-DPAT.
    Bouhelal R; Mir AK
    Br J Pharmacol; 1992 Jan; 105(1):159-63. PubMed ID: 1534503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent observations on new potential and established antidepressant drugs.
    Carlsson A
    Pharmacopsychiatria; 1982 Jul; 15(4):116-20. PubMed ID: 6216489
    [No Abstract]   [Full Text] [Related]  

  • 18. How do antidepressants work?
    Rowe PM
    Mol Med Today; 1995 Dec; 1(9):395. PubMed ID: 9415187
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of variation over 24-hours in response to stimulation of 5-HT1 receptors in the mouse brain.
    Moser PC; Redfern PH
    Chronobiol Int; 1985; 2(4):235-8. PubMed ID: 2966688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down regulation of serotonin uptake sites in rat brain induced by concomitant chronic administration of desipramine and repeated stress.
    Nankai M; Yamada S; Toru M
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):105-6. PubMed ID: 1753449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.